{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T22:02:56Z","timestamp":1771279376599,"version":"3.50.1"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Impact Mechanism and Risk Prediction of Clock Genes in Preeclampsia with Different Blood Pressure Patterns","award":["QNXM2024040"],"award-info":[{"award-number":["QNXM2024040"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic hypertension, gestational hypertension (GH), and preeclampsia (PE) together comprise hypertensive disorders complicating pregnancy. They are one of the most common complications of pregnancy. Aberrant microRNA expression may signal PE and adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Investigating the clinical significance of miR-590-5p in assessing the severity of PE and predicting adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 240 subjects were enrolled in this study, including 60 patients with GH, 120 patients with PE, and 60 healthy controls. The PE group consisted of 60 mild PE (MP) and 60 severe PE (SP). The Quantitative reverse transcription PCR (RT-qPCR) was employed to detect the serum miR-590-5p expression. Receiver operating characteristic curves and logistic regression were used to analyze their diagnostic value. PE patients were grouped by miR-590-5p expression and followed until delivery. The Kaplan-Meier method was employed to investigate the influence of miR-590-5p expression on pregnancy outcome in patients with PE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MiR-590-5p expression was increased in GH, which was further elevated in PE. MiR-590-5p expression was shown to be greater in SP than in MP. MiR-590-5p could differentiate between GH\/PE (area under the curve [AUC]\u2009=\u20090.921, sensitivity\u2009=\u200980.0%, specificity\u2009=\u200991.7%) and MP\/SP (AUC\u2009=\u20090.910, sensitivity\u2009=\u200982.0%, specificity\u2009=\u200985.0%). The level of miR-590-5p expression was correlated positively with blood pressure, urinary protein, and creatinine, and negatively with platelets and neonatal weight. The miR-590-5p high-expression group of patients had a lower probability of normal delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Upregulation of miR-590-5p might help to diagnose PE, depicting the severity of PE, and positively correlate with adverse pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajh\/hpaf191","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T11:48:38Z","timestamp":1758196118000},"page":"452-458","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility of miR-590-5p as a Biomarker for Stratifying Disease Severity and Anticipating Adverse Perinatal Outcomes in Preeclamptic Patients"],"prefix":"10.1093","volume":"39","author":[{"given":"Yanan","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, State Grid Corporation of China Beijing Electric Power Hospital , Beijing,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Ultrasound Medicine, Jinjiang Municipal Hospital , Jinjiang,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital , Suzhou,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,20]]},"reference":[{"key":"2026021616022566100_hpaf191-B1","doi-asserted-by":"crossref","first-page":"e071653","DOI":"10.1136\/bmj-2022-071653","article-title":"Hypertensive disorders of pregnancy","volume":"381","author":"Wu","year":"2023","journal-title":"BMJ"},{"key":"2026021616022566100_hpaf191-B2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.metabol.2017.11.011","article-title":"Hypertensive complications of pregnancy: a clinical overview","volume":"86","author":"Antza","year":"2018","journal-title":"Metabolism"},{"key":"2026021616022566100_hpaf191-B3","doi-asserted-by":"crossref","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century","volume":"226","author":"Fishel Bartal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"2026021616022566100_hpaf191-B4","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"2026021616022566100_hpaf191-B5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/HJH.0b013e32833a39d0","article-title":"Preeclampsia and future maternal health","volume":"28","author":"Carty","year":"2010","journal-title":"J Hypertens"},{"key":"2026021616022566100_hpaf191-B6","doi-asserted-by":"crossref","first-page":"883404","DOI":"10.3389\/fimmu.2022.883404","article-title":"Inflammation in preeclampsia: genetic biomarkers, mechanisms, and therapeutic strategies","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"2026021616022566100_hpaf191-B7","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026021616022566100_hpaf191-B8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-0528.1998.tb09971.x","article-title":"Does gestational hypertension become pre-eclampsia?","volume":"105","author":"Saudan","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"2026021616022566100_hpaf191-B9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: its pathogenesis and pathophysiolgy","volume":"27","author":"Gathiram","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"2026021616022566100_hpaf191-B10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"2026021616022566100_hpaf191-B11","first-page":"1","article-title":"Hypertensive disorders of pregnancy: strategy to develop clinical peptide biomarkers for more accurate evaluation of the pathophysiological status of this syndrome","volume":"94","author":"Araki","year":"2020","journal-title":"Adv Clin Chem"},{"key":"2026021616022566100_hpaf191-B12","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"key":"2026021616022566100_hpaf191-B13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/451414a","article-title":"Molecular biology: the expanding world of small RNAs","volume":"451","author":"Grosshans","year":"2008","journal-title":"Nature"},{"key":"2026021616022566100_hpaf191-B14","first-page":"476","article-title":"Association of circulating miRNA expression with preeclampsia, its onset, and severity","volume":"11","author":"Kolkova","year":"2021","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"2026021616022566100_hpaf191-B15","doi-asserted-by":"crossref","first-page":"e7515","DOI":"10.1097\/MD.0000000000007515","article-title":"MiR-210 and miR-155 as potential diagnostic markers for pre-eclampsia pregnancies","volume":"96","author":"Gan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2026021616022566100_hpaf191-B16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12884-025-07424-3","article-title":"Increased circulating miR-155 identifies a subtype of preeclamptic patients","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026021616022566100_hpaf191-B17","doi-asserted-by":"crossref","first-page":"101402","DOI":"10.1016\/j.redox.2019.101402","article-title":"miR-30-5p-mediated ferroptosis of trophoblasts is implicated in the pathogenesis of preeclampsia","volume":"29","author":"Zhang","year":"2020","journal-title":"Redox Biol"},{"key":"2026021616022566100_hpaf191-B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.placenta.2023.10.004","article-title":"MiR-135b-5p targets ADAM12 to suppress invasion and accelerate trophoblast apoptosis in preeclampsia","volume":"143","author":"Sun","year":"2023","journal-title":"Placenta"},{"key":"2026021616022566100_hpaf191-B19","first-page":"100593","article-title":"miR-590\u20135p: a double-edged sword in the oncogenesis process","volume":"32","author":"Barwal","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"2026021616022566100_hpaf191-B20","doi-asserted-by":"crossref","first-page":"645475","DOI":"10.3389\/fonc.2021.645475","article-title":"Circulating miR-320a acts as a tumor suppressor and prognostic factor in non-small cell lung cancer","volume":"11","author":"Khandelwal","year":"2021","journal-title":"Front Oncol"},{"key":"2026021616022566100_hpaf191-B21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/cas.14199","article-title":"Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer","volume":"111","author":"Khandelwal","year":"2020","journal-title":"Cancer Sci"},{"key":"2026021616022566100_hpaf191-B22","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1080\/14767058.2019.1569614","article-title":"Trimester-specific plasma exosome microRNA expression profiles in preeclampsia","volume":"33","author":"Devor","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026021616022566100_hpaf191-B23","first-page":"227","article-title":"[Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020)]","volume":"55","author":"Hypertensive Disorders in Pregnancy Subgroup CSoOaG, Chinese Medical Association","year":"2020","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2026021616022566100_hpaf191-B24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.gene.2018.10.015","article-title":"MicroRNA-431 affects trophoblast migration and invasion by targeting ZEB1 in preeclampsia","volume":"683","author":"Yang","year":"2019","journal-title":"Gene"},{"key":"2026021616022566100_hpaf191-B25","first-page":"3938","article-title":"MiR-296-3p promotes the development and progression of preeclampsia via targeting the CEMIP","volume":"25","author":"Li","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026021616022566100_hpaf191-B26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12884-022-04785-x","article-title":"High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes","volume":"22","author":"He","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026021616022566100_hpaf191-B27","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3892\/etm.2017.4212","article-title":"An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension","volume":"13","author":"Mei","year":"2017","journal-title":"Exp Ther Med"},{"key":"2026021616022566100_hpaf191-B28","first-page":"28","article-title":"MicroRNAs in preeclampsia","volume":"8","author":"Skalis","year":"2019","journal-title":"MicroRNA (Shariqah, United Arab Emirates)"},{"key":"2026021616022566100_hpaf191-B29","first-page":"e31143","article-title":"Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors","volume":"14","author":"Khan","year":"2022","journal-title":"Cureus"},{"key":"2026021616022566100_hpaf191-B30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.placenta.2018.01.007","article-title":"Identification of potential early biomarkers of preeclampsia","volume":"63","author":"Timofeeva","year":"2018","journal-title":"Placenta"},{"key":"2026021616022566100_hpaf191-B31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preghy.2023.10.011","article-title":"First trimester circulating miR-194-5p and miR-1278 improve prediction of preeclampsia","volume":"34","author":"Cl\u00e9Ment","year":"2023","journal-title":"Pregnancy Hypertens"},{"key":"2026021616022566100_hpaf191-B32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41598-020-57838-6","article-title":"Circulating miR-330-3p in late pregnancy is associated with pregnancy outcomes among lean women with GDM","volume":"10","author":"Pfeiffer","year":"2020","journal-title":"Sci Rep"},{"key":"2026021616022566100_hpaf191-B33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/03630242.2022.2108193","article-title":"Diagnostic value of serum miR-25-3p in hypertensive disorders in pregnancy","volume":"62","author":"Zhou","year":"2022","journal-title":"Women Health"},{"key":"2026021616022566100_hpaf191-B34","doi-asserted-by":"crossref","first-page":"108366","DOI":"10.1016\/j.abb.2020.108366","article-title":"AK002210 promotes the proliferation, migration and invasion of trophoblast cell through regulating miR-590\/NAIP signal axis","volume":"688","author":"Zhao","year":"2020","journal-title":"Arch Biochem Biophys"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf191\/64331745\/hpaf191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/3\/452\/64331745\/hpaf191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/39\/3\/452\/64331745\/hpaf191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:35Z","timestamp":1771275755000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/39\/3\/452\/8259611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,20]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9,20]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf191","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,9,20]]}}}